2022 Conference
25th European GERPAC Conference
October 5, 6 & 7, 2022 - Hyères - France
In this space, you will find all the congress communications including conferences, round table, short oral communications and poster presentations.
Testimonials
Opening of the conference
Concurrent workshops
Learning through games: an innovative way to learn good hygiene practices in cleanrooms
A. Garnier, P. Bonnabry (Genève - Switzerland)
How can the robustness and safety of hospital production be optimized by monitoring relevant indicators? P. Odou, M. Bouchfaa (Lille - France) Outsourcing of chemotherapy preparations: practical exercises M-L. Brandely-Piat (Paris - France)
J-M. Canonge (Toulouse - France)
F. Lepagnol (ARS Ile-de-France)
BPPs and degraded procedures V. Salomon (Paris - France)
T. Storme (Paris - France)
J-Ph. Poulet (Lyon - France) Automation in hospital pharmacy: Technics and expectations I. Kramer (Mainz - Germany), P. Le Brun (Leiden - The Netherland), F. Sadeghipour (Lausanne - Switzerland)
How can the robustness and safety of hospital production be optimized by monitoring relevant indicators? P. Odou, M. Bouchfaa (Lille - France) Outsourcing of chemotherapy preparations: practical exercises M-L. Brandely-Piat (Paris - France)
J-M. Canonge (Toulouse - France)
F. Lepagnol (ARS Ile-de-France)
BPPs and degraded procedures V. Salomon (Paris - France)
T. Storme (Paris - France)
J-Ph. Poulet (Lyon - France) Automation in hospital pharmacy: Technics and expectations I. Kramer (Mainz - Germany), P. Le Brun (Leiden - The Netherland), F. Sadeghipour (Lausanne - Switzerland)
Training and Evaluation
Access to replay of these recorded presentations
Access is restricted to GERPAC members and to those registered for the distance learning format of this 2022 edition.
Moderators
S Crauste-Manciet (Angers - France)D Lannoy (Lille - France)
"Practical pharmaceutics" Edition 2
P. Le Brun ( (Leiden -The Netherland)
Innovative educational approaches for pharmaceutical technology training
Pr Pascal BONNABRY Pharmacy, Geneva University Hospitals (HUG),
Institute of Pharmaceutical Sciences of Western Switzerland (ISPSO), Section of pharmaceutical sciences, University of Geneva, Switzerland
Framework for the assessment of compliance with practices for the safe handling of hazardous drugs
JF Bussières, C Tanguay (Montréal - Canada)
Collaboration work with the SFPC on the infusion of injectable medecines
P. Chennel (Clermont-Ferrand - France)
European Experience Round Table: Improving the stability of reconstituted injectable solutions
Access to replay of these recorded presentations
Access is restricted to GERPAC members and to those registered for the distance learning format of this 2022 edition.
Moderators
S Crauste-Manciet (Angers - France)P Chennell (Clermont-Ferrand - France)
Expert Discussion
T. Schnor (Copenhague - Denmark), J. Smith (Cardiff - UK), P. Le Brun (Leyden - Netherlands), I. Kramer (Mainz - Germany), JD. Hecq (Namur - Belgium), J. Vigneron (Nancy - France), T. Agasoster (Oslo - Norway)
Paediatrics
Access to replay of these recorded presentations
Access is restricted to GERPAC members and to those registered for the distance learning format of this 2022 edition.
Moderators
F Lagarce (Angers - France)F Marçon (Amiens - France)
Potential impact of dose-banding for anticancer therapy in paediatrics based on pharmacokinetics
M. White-Koning (Toulouse - France)
Lactarium: Good practices and freeze-drying
A. Jourand (Bordeaux - France)
Acceptability of paediatric medicines: just a matter of taste?
F. Marçon (Amiens - France)
Medication in newborns and exposure to parabens
A. Dupuis (Poitiers - France)
Allergology
Access to replay of these recorded presentations
Access is restricted to GERPAC members and to those registered for the distance learning format of this 2022 edition.
Moderators
D Brossard (Paris - France)Y. Soulairol (Nîmes - France)
Medicinal preparations in allergology: pharmaceutical issues
D. Lannoy (Lille - France)
Industrial preparations of Named Patient Products (NPPs) in allergology
S. Slimani (Antony - France)
Hot topics 2022 Hospital Pharmaceutical Technologies
Access to replay of these recorded presentations
Access is restricted to GERPAC members and to those registered for the distance learning format of this 2022 edition.
Moderatos
D Brossard (Paris - France)Y. Soulairol (Nîmes - France)
Medicines with supply issues and BPPs
V. Salomon (ANSM - France)
The development of fumagillin at HCL
F. Pirot (Lyon - France)
Constitution of a national group of external quality assesment for the hospitals control laboratories
C. Merienne (Lyon - France)
GERPAC 2022 Multimedia support Contest
Pharmaceutical Technology Master course’s award
Access to replay of these recorded presentations
Access is restricted to GERPAC members and to those registered for the distance learning format of this 2022 edition.
Moderators
F Lagarce (Angers - France)F Marçon (Amiens - France)
Developement of an oral form of vinorelbine for pediatric use in the treatment of rhabdomyosarcoma
J-C. Mabin1 , F-X. Legrand2, L. Denis1, A.Doweki1, 3, M. Annereau 1, 4, A. Rieutord11 Clinical Pharmacy Department, Gustave Roussy Cancer Campus, 94800 Villejuif, France
2 Paris-Saclay University, CNRS, Galien Institute Paris-Saclay, 91190, Orsay, France.
3 Paris-Saclay University, Lipids: analytical and biological systems, 91190, Orsay, France.
4 Paris-Saclay University, Matériaux et santé, 91190, Orsay, France.
Impact of disposable syringes type choice on myocardial perfusion imaging procedures with [99mTc]Tc-tetrofosmin
T. Ladriere1,2 , C. Desmonts 1, 3, P.-A. Zimmermann 1, D. Peyronnet 1, 2, D. Agostini 1, 4, J. Vigne 1, 2, 5
1 Department of Nuclear Medicine, CHU de Caen Normandie, Normandy University, UNICAEN, 14000 Caen, France.2 Department of Pharmacy, CHU de Caen Normandie, Normandy University, UNICAEN, 14000 Caen, France.
3 Normandie Université, UNICAEN, INSERM U1086, INSERM ANTICIPE, Caen 14000, France
4 Normandie Université, UNICAEN, UR 4650, Caen 14000, France
5 Normandie Université, UNICAEN, INSERM U1237, PhIND, Institut Blood and Brain @ Caen Normandie, Centre Cyceron, Caen 14000, France.
GERPAC award 2022 for the best oral communication
GERPAC award 2022 for the best oral communication
Monitoring of potential endocrine disruptor plastic additives by UHPLC-HRMS in prefilled plastic packaging in a hospital setting
W. Bello1,2,3,4, J. Pezzatti1, S. Rudaz3,4, and F. Sadeghipour1,2,3,41 Service of Pharmacy, Lausanne University Hospital
2 Center for Research and Innovation in Clinical Pharmaceutical Sciences, Lausanne University Hospital and University of Lausanne
3 School of Pharmaceutical Sciences, University of Geneva, Geneva, Switzerland
4 Institute of Pharmaceutical Sciences of Western Switzerland, University of Geneva, Geneva, Switzerland
Development and characterization of an oral formulation of nicardipine compounded with simple excipients for the treatment of pediatric hypertension
M. Cavelier1, H. Gondé1, D. Fuss1, D. Costa2, F. Lamoureux3, T. Pereira3, R. Varin1, C. Hervouët11 Pôle pharmacie, CHU de Rouen, 1 rue de Germont, 76000 Rouen, France
2 Laboratoire de parasitologie – mycologie, CHU de Rouen, 1 rue de Germont, 76000 Rouen, France
3 Laboratoire de pharmacologie – toxicologie, CHU de Rouen, 1 rue de Germont, 76000 Rouen, France
Short oral communications
Moderators
Y. Huon (Liège - Belgium)F. Lagarce (Angers - France)
F. Sadeghipour (Lausanne - Switzerland)
Comparative study of sorption phenomena between syringes made of cyclic olefin copolymer or polypropylene and three medications.
J. Claves1, P. Chennell1, N. Krautwurst2, V. Sautou11 Université Clermont Auvergne, CHU Clermont Ferrand, Clermont Auvergne INP, CNRS, ICCF,
F-63000 Clermont-Ferrand, France
2 SCHOTT Schweiz AG, St. Josefen-Strasse 20, 9001 St. Gallen, Switzerland
ValiStab®, a new tool to help carry out a physicochemical stability study
D’Huart E.1,2, Vigneron J.1,2, Demore B.1,2,3. 1 Pharmacie à Usage Intérieur, Hôpitaux de Brabois, 54511 Vandœuvre-lès-Nancy, France.
2 Infostab, non-profit association, Heillecourt, France
3 Université de Lorraine, EA 4360 APEMAC, Nancy, France.
Development of a Letermovir oral solution for anti-cytomegalovirus prophylaxis in children
C. Devant, A. Schweitzer-Chaput, P. Marchadour, A-S. Fauqueur, C. Cotteret, S. CisterninoPharmacy - University Hospital Necker - Enfants Malades, APHP, Paris Cité University, Paris, France
Biological stability of Pembrolizumab after dilution and storage in 0.9% NaCl infusion polyolefin bags
A. Acramel1,2, G. Le Guyader3,4, K. Avrillon4, L. Guyonnet5, J. Denizeau6,7, L. Escalup1, R. Desmaris1, E. Piaggio6,7, C. Guerin5, C. Sedlik6,71 Institut Curie, PSL Research University, Pharmacie Department, F-75005 Paris, France
2 Université Paris Cité, CiTCoM, UMR8038 CNRS, U1268 Inserm, F-75006 Paris, France
3 APHP, Hôpital Henri Mondor, Pharmacie, F-94090 Créteil, France
4 Centre Hospitalier Intercommunal de Créteil, Pharmacie, F-94000 Créteil, France
5 Institut Curie, Cytometry Platform, F-75005 Paris, France
6 Institut Curie, PSL Research University, Translational Research Department, F-75005 Paris, France
7 Inserm U932, F-75005 Paris, France
Creation and implementation of an enabling blended learning course in a quality control laboratory
M. Stoops1, R. Mazet1, M Durand1, J. Leenhardt1,2, M-D. Desruet1,2, P. Bedouch1,31. Département de Pharmacie, Centre Hospitalier Universitaire Grenoble Alpes, France
2. Laboratoire de Bioclinique Radiopharmacie, Université Grenoble Alpes, France
3. ThEMAS, TIMC UMR CNRS 5525, Université Grenoble Alpes, France
Capillary electrophoresis in parenteral nutrition control – Validation of two analytical method: Amino acids/Glucose/Glucose-1-Phosphate and Ka/Na/Ca/Mg
C Fanjeaux, R Vazquez, MN Guerrault-Moro, AC LagraveService Pharmacie, Centre Hospitalier Intercommunal Poissy-Saint-Germain-en-Laye
Alertness of in-process controls: feedback on two production errors
A. Cataldi1, C. Fanjeaux1, R. Vazquez1, M-N. Guerrault-Moro1, A-C. Lagrave11 Service Pharmacie, Centre Hospitalier Intercommunal Poissy-Saint-Germain-en-Laye, France
Chemotherapy manufacturing in a rescue unit for 6 months: a big challenge !
C. Renzullo1, J. Lombardi1, J-F. Penaud1,B. Leroy1, F. Plassard2, S. Kirche3, J. Coutet1
1 Pharmacie2 Services Techniques
3 Biomédical
Centre Hospitalier de Chalon Sur Saône, 4 rue du Capitaine Drillien, France
Validation of a compounding process for injectable dopamine in an anaerobic chamber for a clinical trial
B. Palas1, D. Lannoy1,2, N. Carta2, C. Nassar1, M. Roche1,2, P. Odou1,21- Pharmacie CHU Lille, France ; 2- Laboratoire de Biopharmacie, Pharmacie Galénique et Hospitalière, UFR3S, Univ Lille, France
Formulation of an oral phosphorus solution adapted to neonatology
J. Convert1, R. Mazet1, F. Basset1, A. Moussali1, S. Chanoine1,2, M. Durand1, M.D. Desruet1, P. Bedouch1,21. Pôle Pharmacie, Centre Hospitalo-Universitaire Grenoble Alpes, Grenoble, France
2. Université Grenoble Alpes, Faculté de. Pharmacie, TIMC UMR CNRS 5525, Grenoble, France
Endotoxin assay optimization and validation in binary parenteral nutrition mixtures
L. Bourgue, M. Teppe, A. Benhabib, L. Gayrard, M. Ben ReguigaService Pharmacie, Centre Hospitalier de Mayotte - Mayotte - France
Implementation of a discrimination strategy for eight monoclonal antibodies by FIA-UV using a confusion matrix: application to pembrolizumab
J. Siboni1, B.Muhiu1, C. Mequinion1, A. Sifaoui1, E. Caudron1,2, L. Lê 1,21 Service de Pharmacie, Hôpital européen Georges Pompidou, APHP Centre Université de Paris, France
2 Equipe Lip(Sys)² Chimie analytique pharmaceutique, Faculté de Pharmacie, Université Paris Saclay, Chatenay-Malabry, France
Efficiency of decontamination procedures for surfaces contaminated with hazardous drugs
N. Clottens., P. Ramaut, T. BautersPharmacy dpt., Ghent University Hospital, C. Heymanslaan 10, Ghent, Belgium
Isolator seal breach: assessment of the leak test relevance and impact on microbiological contamination risk
G. Guilanpour, E. Gasperi, F. Bordet, M-L. MaestroniService Pharmacie, Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France
Formulation and bioavilability study of a gemcitabine intravesical thermoreversible gel for bladder carcinoma treatment
E. Vissac1, Z. Mokdadi1, M. Venet1, M. Colombel3, C. Marchand1, C. Merienne1, Fabrice Pirot1,2
1 Hospices Civils de Lyon - Unité de Préparation et de Contrôle des Médicaments, plateforme FRIPHARM, Pharmacie à usage intérieur, Groupement Hospitalier Edouard Herriot
2 Hospices Civils de Lyon - Pharmacie à usage intérieur, Groupement Hospitalier Edouard Herriot
3 Service d’Urologie, Hospices Civils de Lyon - Faculté de Médecine Lyon Est, France
Evaluation of UV-light-shielding bags efficiency on dacarbazine photodegradation
M. Sangnier1, J-M. Bernadou1, M. Noguero1, G. Bouguéon1,2, A. Berroneau1, S. Crauste-Manciet1,21 Pharmaceutical Technology Department, Bordeaux University Hospital, Avenue de Magellan, 33604 Pessac, France
2 ARNA Laboratoire ChemBioPharm U1212 INSERM - UMR 5320 CNRS, Université de Bordeaux, France
Aerosolisation’s risk assessment of bacteriophages handled in a biological safety cabinet
B. Lapras1,4,C. Moreau1, M. Medina2,4, C. Marchand1,4, C. Merienne1,4, C. Kolenda2,4, T. Briot3,4, G. Leboucher3,4, F. Laurent2,4, F. Pirot1,41 Plateforme FRIPHARM, Pharmacie à usage intérieur, Groupement Hospitalier Centre - Hospices Civils de Lyon (HCL)
2 Laboratoire de bactériologie, Centre national de référence des staphylocoques – Hospices Civils de Lyon
3 Pharmacie à usage intérieur, Groupement Hospitalier Nord – Hospices Civils de Lyon
4 Consortium PHAG-ONE – PHAGinLyon
Determination of the residual hemolytic activity of a purified bacteriophage suspension
M. Pichon-Pramil1, B. Lapras1, M. Medina2, M. Cristofoli1, C. Marchand1, C. Merienne1, F. Laurent2, F. Pirot11 Unité de Préparation et de Contrôle des Médicaments, plateforme FRIPHARM, Pharmacie à Usage Intérieur, Groupement Hospitalier Edouard Herriot – Hospices Civils de Lyon
2 Institut des Agents Infectieux, Laboratoire de Biologie et d’Anatomie Pathologique, Groupement Hospitalier Croix Rousse - Hospices Civils de Lyon
Monitoring of surface chemical contamination in a robotized chemotherapy preparation process
M. Bouchfaa1,2, A. Lecoutre1, J. Courtin1, M. Pinturaud1, M. Vasseur1,2, S. Nicolas1,2, P. Odou1,21- CHU Lille, Institut de pharmacie, F-59000 Lille, France
2- Univ. Lille, EA 7365 – GRITA – Groupe de Recherches sur les formes Injectables et les Technologies Associées, F-59000 Lille, France
Formulation and evaluation of physicochemical stability of Allopurinol 20mg/mL oral suspension
V. Baillieu, P. Claraz, C. Sanchez, S. Benakouche, J. Le Liboux, V. Vasseur, T. Storme, A. SabriHôpital Robert Debré, 48 Bd Sérurier, 75019 Paris, France
Visual facilitation of procedures in the cytotoxic reconstitution unit (CRU)
A.Charlier, H.Rucheton, C.Nowak, I.BaudinPharmacie - Centre Hospitalier d’Angoulême - France
Update on osmolality of oral medications and enteral nutrition used in neonatal department
A. Hlavaty1, R. Mazet1, M. Durand1, S. Chanoine1,2, MD. Desruet1 , P. Bedouch1,21 - Pôle Pharmacie, Centre Hospitalo-Universitaire Grenoble Alpes, France
2 - TIMC UMR CNRS 5525, Université Grenoble Alpes, France
E-Posters: Analytical - Control - Microbiology
Analytical validation of a cation assay in binary parenteral nutrition with capillary electrophoresis
T. Pillot, M. Dumas, D. Reitter, N. Chouaou, P. Aouizerate, R. Tang, C. Cuvelier, S. Coulon
Grand hôpital de l’Est francilien, Jossigny, France Development and validation of a dosing method for colchicine capsules for a stability study N. Kervella, A. Bourges, V. Lebreton
CHU d’Angers, France Isothermal cases qualified by the suppliers: are-they suitable for the transport of heat-sensitive cytotoxic preparations? E. Allouis, M. Renault-Mahieux, E. Malluile, V. Vieillard, W. Saeed, S. Marque, M. Paul, M. Carvalho
Hôpital Henri Mondor, Créteil, France Development and validation of a method for the quantitative determination of baclofen and its degradation products for the stability study of experimental medicine Z. Mokdadi, E. Vissac, M. Venet, C. Marchand, C. Dhelens, C. Merienne, F. Pirot
Hôpital Edouard Herriot, Lyon, France Development and validation of a method for the quantitative determination of baclofen and its degradation products for the stability study of experimental medicine. Z. Mokdadi1, E. Vissac1, M. Venet1, C. Marchand1, C. Dhelens1, C. Merienne1, F. Pirot1, 2
[1] : Pharmacie, Hôpital Edouard Herriot, Lyon France
[2] : Laboratoire de Pharmacie Galénique Industrielle, ISPB, Lyon, France
Development and validation of sterility method by membrane filtration of 5% vancomycin eye drops L. Rodrigo, M. Bourget, E. Olivier, N. Cormier
CHU de Nantes Hôtel-Dieu, France Validation of an assay method for riboflavin hospital capsule preparation B. Querin, A. Schweitzer Chaput, P. Ober, A. Fauqueur, A. Negbane, S. Cisternino, C. Cotteret
Hôpital Universitaire Necker - Enfants Malades, Paris, France Determination of ions in paediatric NPI bags using a microwave plasma atomic emission spectrometer: not so easy for the pharmacist! C. Salvez, L. Delnoy, E. Baba, C. Monchy, , W. David, C. Skorka, S. Bulcourt, D. Dautel.
Valenciennes Hospital Center - France Development and validation of an analytical method for the assessment of methylparaben and propylparaben by HPLC-UV A. Sauvaget, J. Robin, G. Binson, A. Dupuis
Hôpital universitaire de Poitiers, France Development and validation of an analytical method for the determination of thiopental for a physicochemical stability study J. Robin1, N. Hami1, A. Sauvaget1, K. Cheroux2, G. Binson1, A. Dupuis1.
1: Pharmacy department, University Hospital of Poitiers, France.
2: Gynaecology department, University Hospital of Poitiers, France. Oral suspension of spironolactone: development and validation of an analytical method by HPLC-UV A. Musicki1, C. Merienne2, C. Marchand2, M. Breniaux1, T. Quessada1
1 : Pharmacie, Hôpital Edouard-Herriot, Lyon, France
2 : Pharmacie, Hôpitaux Louis Pradel, Lyon, France Validation of an alternative method for sterility control of parenteral nutrition mixtures J-C. Mabin, C. Tournus, C. Chaplain, A. Diallo, X. Deviot
Centre Hospitalier de Saint-Denis, France
Grand hôpital de l’Est francilien, Jossigny, France Development and validation of a dosing method for colchicine capsules for a stability study N. Kervella, A. Bourges, V. Lebreton
CHU d’Angers, France Isothermal cases qualified by the suppliers: are-they suitable for the transport of heat-sensitive cytotoxic preparations? E. Allouis, M. Renault-Mahieux, E. Malluile, V. Vieillard, W. Saeed, S. Marque, M. Paul, M. Carvalho
Hôpital Henri Mondor, Créteil, France Development and validation of a method for the quantitative determination of baclofen and its degradation products for the stability study of experimental medicine Z. Mokdadi, E. Vissac, M. Venet, C. Marchand, C. Dhelens, C. Merienne, F. Pirot
Hôpital Edouard Herriot, Lyon, France Development and validation of a method for the quantitative determination of baclofen and its degradation products for the stability study of experimental medicine. Z. Mokdadi1, E. Vissac1, M. Venet1, C. Marchand1, C. Dhelens1, C. Merienne1, F. Pirot1, 2
[1] : Pharmacie, Hôpital Edouard Herriot, Lyon France
[2] : Laboratoire de Pharmacie Galénique Industrielle, ISPB, Lyon, France
Development and validation of sterility method by membrane filtration of 5% vancomycin eye drops L. Rodrigo, M. Bourget, E. Olivier, N. Cormier
CHU de Nantes Hôtel-Dieu, France Validation of an assay method for riboflavin hospital capsule preparation B. Querin, A. Schweitzer Chaput, P. Ober, A. Fauqueur, A. Negbane, S. Cisternino, C. Cotteret
Hôpital Universitaire Necker - Enfants Malades, Paris, France Determination of ions in paediatric NPI bags using a microwave plasma atomic emission spectrometer: not so easy for the pharmacist! C. Salvez, L. Delnoy, E. Baba, C. Monchy, , W. David, C. Skorka, S. Bulcourt, D. Dautel.
Valenciennes Hospital Center - France Development and validation of an analytical method for the assessment of methylparaben and propylparaben by HPLC-UV A. Sauvaget, J. Robin, G. Binson, A. Dupuis
Hôpital universitaire de Poitiers, France Development and validation of an analytical method for the determination of thiopental for a physicochemical stability study J. Robin1, N. Hami1, A. Sauvaget1, K. Cheroux2, G. Binson1, A. Dupuis1.
1: Pharmacy department, University Hospital of Poitiers, France.
2: Gynaecology department, University Hospital of Poitiers, France. Oral suspension of spironolactone: development and validation of an analytical method by HPLC-UV A. Musicki1, C. Merienne2, C. Marchand2, M. Breniaux1, T. Quessada1
1 : Pharmacie, Hôpital Edouard-Herriot, Lyon, France
2 : Pharmacie, Hôpitaux Louis Pradel, Lyon, France Validation of an alternative method for sterility control of parenteral nutrition mixtures J-C. Mabin, C. Tournus, C. Chaplain, A. Diallo, X. Deviot
Centre Hospitalier de Saint-Denis, France
E-Posters: Contamination - Microbiologiy - Stability
Evolution of chemical contamination in a Cytotoxic Reconstitution Unit
J. Gallot-Lavallée, S. Himoudi, I. Hennebelle, Y. Cretu, M. Caucat, S. Herioux, F. Puisset, S. Perriat, JM. Canonge
Institut Universitaire du Cancer de Toulouse - Oncopôle, France Clean room : mapping of microbiological samples of the environment using a Failure Mode an Effect Analysis (FMEA) method F. Rivals, G. Bouguéon, M. Sangnier, M. Saly, H. Boulestreau, A. Berroneau, S. Crauste-Manciet
CHU de Bordeaux, France Stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin IV bags V. Vieillard, M. Paul
CHU Henri Mondor, Créteil, France Physicochemical stability of daratumumab SC (DARZALEX® 1800 mg injection solution) in plastic syringes over a period of 28 days stored refrigerated or at room temperature L. Knoll, J. Thiesen, M. Klaßen, L. Reinders, J. Türk, I. Krämer
University Medical Center Mainz, Germany Physicochemical stability study of cabazitaxel Zentiva® in vials after “opening” and in diluted solutions in 3 types infusion bags E. D’Huart, M. Sacrez, N. Sobalak, J. Vigneron, B. Demore
CHU Nancy, Infostab, France A study of the stability of Ceftriaxone preparations in two vehicles for epicutaneous allergy tests I. Belaid, T. Pereira, H. Gondé, M. Cavelier, F. Lamoureux, R. Varin, C. Hervouet
Hôpital Lariboisière, AP-HP Paris, CHU Rouen, France Microbial contamination of isolators: from risk analysis to decision-making flowchart E. Seguin, S. Martelli, M-L. Brandely-Piat, M. Jobard, R. Batista
Université de Paris Cité - site Cochin, Paris, France Evaluation of surface contamination with cyclophosphamide and paclitaxel to control the risk of occupational exposure to hazardous drugs in two hospitals of a comprehensive cancer center C. Ulian, J. Fouque, M. Lafay, C. Matta, N. Subramanian, O. Collin, S. Huguet, K. Rezai, O. Madar,
R. Desmaris, L. Escalup, B. Haney-Teillaud, A. Acramel
Institut Curie, Paris Biological stability of Durvalumab solutions in its opened vials or after dilution and storage in 0.9% NaCl infusion polyolefin bags A. Acramel, G. Le Guyader, K. Avrillon, L. Guyonnet, J. Denizeau, L. Escalup, R. Desmaris, E. Piaggio, C. Guerin, C. Sedlik
Institut Curie Paris, Hôpital Henri Mondor AP-HP Paris, CHI Créteil, France Microbiological stability of Rituximab bags A. Iwanoff, C. Djayet, A-S. Martin, C. Davoine, F. El Alaoui, M. Rigal, A. Jacolot, M. Apparuit
Hôpital Avicenne, Bobigny, France Improving flows to limit particulate contaminants in sterile preparation areas F. Giannelli, C. Figeac, M-D. Desruet, M. Durand, P. Bedouch
Centre Hospitalier Universitaire Grenoble Alpes, France Method validation in preservation of sterile agar plates beyond the manufacturers’ recommendations for use in a compounding unit M. Caudron, N.D. Alloh, A. Nowak, A. Fillatre, M. Royer, L. Mustapha, F. Marçon
CHU Amiens, France
Institut Universitaire du Cancer de Toulouse - Oncopôle, France Clean room : mapping of microbiological samples of the environment using a Failure Mode an Effect Analysis (FMEA) method F. Rivals, G. Bouguéon, M. Sangnier, M. Saly, H. Boulestreau, A. Berroneau, S. Crauste-Manciet
CHU de Bordeaux, France Stability study of a biosimilar of Bevacizumab in vials and after dilution in 0.9% NaCl in polyolefin IV bags V. Vieillard, M. Paul
CHU Henri Mondor, Créteil, France Physicochemical stability of daratumumab SC (DARZALEX® 1800 mg injection solution) in plastic syringes over a period of 28 days stored refrigerated or at room temperature L. Knoll, J. Thiesen, M. Klaßen, L. Reinders, J. Türk, I. Krämer
University Medical Center Mainz, Germany Physicochemical stability study of cabazitaxel Zentiva® in vials after “opening” and in diluted solutions in 3 types infusion bags E. D’Huart, M. Sacrez, N. Sobalak, J. Vigneron, B. Demore
CHU Nancy, Infostab, France A study of the stability of Ceftriaxone preparations in two vehicles for epicutaneous allergy tests I. Belaid, T. Pereira, H. Gondé, M. Cavelier, F. Lamoureux, R. Varin, C. Hervouet
Hôpital Lariboisière, AP-HP Paris, CHU Rouen, France Microbial contamination of isolators: from risk analysis to decision-making flowchart E. Seguin, S. Martelli, M-L. Brandely-Piat, M. Jobard, R. Batista
Université de Paris Cité - site Cochin, Paris, France Evaluation of surface contamination with cyclophosphamide and paclitaxel to control the risk of occupational exposure to hazardous drugs in two hospitals of a comprehensive cancer center C. Ulian, J. Fouque, M. Lafay, C. Matta, N. Subramanian, O. Collin, S. Huguet, K. Rezai, O. Madar,
R. Desmaris, L. Escalup, B. Haney-Teillaud, A. Acramel
Institut Curie, Paris Biological stability of Durvalumab solutions in its opened vials or after dilution and storage in 0.9% NaCl infusion polyolefin bags A. Acramel, G. Le Guyader, K. Avrillon, L. Guyonnet, J. Denizeau, L. Escalup, R. Desmaris, E. Piaggio, C. Guerin, C. Sedlik
Institut Curie Paris, Hôpital Henri Mondor AP-HP Paris, CHI Créteil, France Microbiological stability of Rituximab bags A. Iwanoff, C. Djayet, A-S. Martin, C. Davoine, F. El Alaoui, M. Rigal, A. Jacolot, M. Apparuit
Hôpital Avicenne, Bobigny, France Improving flows to limit particulate contaminants in sterile preparation areas F. Giannelli, C. Figeac, M-D. Desruet, M. Durand, P. Bedouch
Centre Hospitalier Universitaire Grenoble Alpes, France Method validation in preservation of sterile agar plates beyond the manufacturers’ recommendations for use in a compounding unit M. Caudron, N.D. Alloh, A. Nowak, A. Fillatre, M. Royer, L. Mustapha, F. Marçon
CHU Amiens, France
E-Posters: Quality Assurance
Risk analysis relating to the implementation of a circuit of advanced therapies medicinal products in a comprehensive cancer center
R. Rekik, A. Acramel, O. Andre, L. Hammoudi, A. Bouyarden, L. Escalup
Institut Curie, Paris, France Constraints and feasibility of filter integrity testing for the production of sterile preparations in hospital pharmacy K. Tardivel, P. Lemoine, E. Fischer, M. Pichon-Pramil, C. Merienne, B. Lapras, M. Cristofoli, C. Marchand, F. Pirot
Groupement Hospitalier Edouard Herriot - Hospices Civils de Lyon, France Feedback: Is it useful to watch all DRUGCAM® videos before delivery? M. Viault, P. Marque, N. Soulet, B. Darricau, T. Boulet, M. Anquetil, S. Rajezakowski
Centre Hospitalier de Niort, France Retrospective differential analysis between 3971 prescriptions of individualized parenteral nutrition and 2 commercial parenteral nutrition M. Royer, A. Léké, F. Marçon
CHU d’Amiens, France Implementation of a continuity plan for Cytotoxic Reconstitution Unit (CRU) in case of cyberattack R. Gallerand, C. Brentot, E. Sigward, M. Andanson-Macchi
CH Montluçon, France Is the chemotherapy circuit with RFID technology a good idea? A. Loison, C. Skorka, D. Dautel, F. Verryser
Centre Hospitalier de Valenciennes, France Visual management SQCDP: a tool for monitoring performance in pharmacotechny unit A. Lassalle-Diguet, A. Andrieu, E. Raingeard, Y. Poirier
CHD Vendée, La Roche sur Yon, France Performance qualifications of sterilization cycle in isolator: Are the qualifications carried out by the manufacturer indisputable? C. Cros, A. Hurgon, A. Acramel, G. Jacquemmoz, R. Desmaris, L. Escalup
Institut Curie, Paris, France Causes determination of noncompliance in the measurement of calcium in parenteral nutrition mixtures J. Nakache, N. Gastaut, H. Baaziz, J. Duquesne, G. Chinetti, S. Ruitort, R. Collomp
CHU de Nice, France « Done for Mrs B ! » : Comparison of a chemotherapy oral validation versus a conventional validation circuit S. Winckel, A. Danckaert, H. Huyghe, D. De Bertoult, P. Carlier, S. Fernandez, L. Real
Centre Hospitalier d’Arras, France Optimisation of the organisation of a Chemotherapy Reconstitution Unit in a French Oversea Territory – Dose standardisation of paclitaxel W. Bopp, S. Istin, A. Zavarro, F. Gonnet, P. Dupire
Centre Hospitalier de Polynésie Française, Papeete, Tahiti Performance qualification (PQ) of a new isolator for reconstitution of cytotoxics J. Gotzamanis, G. Bouguéon, M. Sangnier, A. Berroneau, S. Crauste-Manciet
CHU de Bordeaux, France
Institut Curie, Paris, France Constraints and feasibility of filter integrity testing for the production of sterile preparations in hospital pharmacy K. Tardivel, P. Lemoine, E. Fischer, M. Pichon-Pramil, C. Merienne, B. Lapras, M. Cristofoli, C. Marchand, F. Pirot
Groupement Hospitalier Edouard Herriot - Hospices Civils de Lyon, France Feedback: Is it useful to watch all DRUGCAM® videos before delivery? M. Viault, P. Marque, N. Soulet, B. Darricau, T. Boulet, M. Anquetil, S. Rajezakowski
Centre Hospitalier de Niort, France Retrospective differential analysis between 3971 prescriptions of individualized parenteral nutrition and 2 commercial parenteral nutrition M. Royer, A. Léké, F. Marçon
CHU d’Amiens, France Implementation of a continuity plan for Cytotoxic Reconstitution Unit (CRU) in case of cyberattack R. Gallerand, C. Brentot, E. Sigward, M. Andanson-Macchi
CH Montluçon, France Is the chemotherapy circuit with RFID technology a good idea? A. Loison, C. Skorka, D. Dautel, F. Verryser
Centre Hospitalier de Valenciennes, France Visual management SQCDP: a tool for monitoring performance in pharmacotechny unit A. Lassalle-Diguet, A. Andrieu, E. Raingeard, Y. Poirier
CHD Vendée, La Roche sur Yon, France Performance qualifications of sterilization cycle in isolator: Are the qualifications carried out by the manufacturer indisputable? C. Cros, A. Hurgon, A. Acramel, G. Jacquemmoz, R. Desmaris, L. Escalup
Institut Curie, Paris, France Causes determination of noncompliance in the measurement of calcium in parenteral nutrition mixtures J. Nakache, N. Gastaut, H. Baaziz, J. Duquesne, G. Chinetti, S. Ruitort, R. Collomp
CHU de Nice, France « Done for Mrs B ! » : Comparison of a chemotherapy oral validation versus a conventional validation circuit S. Winckel, A. Danckaert, H. Huyghe, D. De Bertoult, P. Carlier, S. Fernandez, L. Real
Centre Hospitalier d’Arras, France Optimisation of the organisation of a Chemotherapy Reconstitution Unit in a French Oversea Territory – Dose standardisation of paclitaxel W. Bopp, S. Istin, A. Zavarro, F. Gonnet, P. Dupire
Centre Hospitalier de Polynésie Française, Papeete, Tahiti Performance qualification (PQ) of a new isolator for reconstitution of cytotoxics J. Gotzamanis, G. Bouguéon, M. Sangnier, A. Berroneau, S. Crauste-Manciet
CHU de Bordeaux, France
E-Posters: Formulation - Production
Dose-capping, dose-adjustment, full-dose: what to do for antineoplastic drugs in obese patients ?
J. Gouju, A. Ifrah, M. Delamotte, L. Le Quay, A. Lebreton, F. Lagarce
CHU d’Angers, France Formulation, particle size and rheological characterization of a pediatric suspension of prazosin for the treatment of post-traumatic night terrors M. Cristofoli, P. Espi, C. Moreau, C. Paillet, C. Marchand, M. Pichon-Pramyl, C. Merienne, F. Pirot
Groupement Hospitalier Edouard Herriot - Hospices Civils de Lyon, France 177Lu-ITG-PSMA-1: Development of a fully automatized in-hospital production J. Delage, J. Costes, K. Casagrande, T. Baumgartner, J. Caputo, J. De Figueiredo, O. Fabre, P. Houlmann, F. Sadeghipour
HU de Lausanne, Suisse Development and validation of [18F]DPA714 automated radiosynthesis, a PET radiotracer for neuroinflammation imaging A. Zavarro, V. Nail, A. Moyon, P. Garrigue, A. Bouhlel, B. Guillet
Centre Européen de Recherche en Imagerie, Marseille, France Spiros® and small administration volume: gravimetric control helps limit waste C. Brentot, E. Sigward, M. Andanson-Macchi
CH Montluçon Néris-les-Bains, France Assessment of the Bexen Medical Col system to prepare autologous serum eyes drops A. Daujat, V. Dias Meireles, L. Rabouam, F. Vallee, A-C. Epinette
Centre Hospitalier Universitaire de Poitiers, France Radiolabelling of erythrocytes with 18FDG : feasibility study J. Costes, J. Delage, K. Casagrande, J. Prior, F. Sadeghipour
HU de Lausanne, Suisse Haloperidol nasal solution: formulation and physicochemical stability study A. Ressault, A. Dory, L. Perello, L. Gheddar, P. Kintz, G. Ubeaud Séquier, B. Gourieux
CHU de Strasbourg, France Development of vinorelbine oral formulations for pediatric use L. Macqueron, L. Regnier, P. Robinet, A-L. Leroy, M-A. Lester, P-N. Boivin, P. Le Corre
Centre Hospitalier Universitaire de Rennes, France Administration devices for oral compounding M. Cavelier, H. Gondé, C. Orsini, A. Coquard, R. Varin, C. Hervouët
CHU de Rouen, France 110 Development and stability of 40 mg/mL amiodarone oral suspension M. Cavelier, H. Gondé, D. Costa, F. Lamoureux, T. Pereira, R. Varin, C. Hervouët
CHU de Rouen, France
CHU d’Angers, France Formulation, particle size and rheological characterization of a pediatric suspension of prazosin for the treatment of post-traumatic night terrors M. Cristofoli, P. Espi, C. Moreau, C. Paillet, C. Marchand, M. Pichon-Pramyl, C. Merienne, F. Pirot
Groupement Hospitalier Edouard Herriot - Hospices Civils de Lyon, France 177Lu-ITG-PSMA-1: Development of a fully automatized in-hospital production J. Delage, J. Costes, K. Casagrande, T. Baumgartner, J. Caputo, J. De Figueiredo, O. Fabre, P. Houlmann, F. Sadeghipour
HU de Lausanne, Suisse Development and validation of [18F]DPA714 automated radiosynthesis, a PET radiotracer for neuroinflammation imaging A. Zavarro, V. Nail, A. Moyon, P. Garrigue, A. Bouhlel, B. Guillet
Centre Européen de Recherche en Imagerie, Marseille, France Spiros® and small administration volume: gravimetric control helps limit waste C. Brentot, E. Sigward, M. Andanson-Macchi
CH Montluçon Néris-les-Bains, France Assessment of the Bexen Medical Col system to prepare autologous serum eyes drops A. Daujat, V. Dias Meireles, L. Rabouam, F. Vallee, A-C. Epinette
Centre Hospitalier Universitaire de Poitiers, France Radiolabelling of erythrocytes with 18FDG : feasibility study J. Costes, J. Delage, K. Casagrande, J. Prior, F. Sadeghipour
HU de Lausanne, Suisse Haloperidol nasal solution: formulation and physicochemical stability study A. Ressault, A. Dory, L. Perello, L. Gheddar, P. Kintz, G. Ubeaud Séquier, B. Gourieux
CHU de Strasbourg, France Development of vinorelbine oral formulations for pediatric use L. Macqueron, L. Regnier, P. Robinet, A-L. Leroy, M-A. Lester, P-N. Boivin, P. Le Corre
Centre Hospitalier Universitaire de Rennes, France Administration devices for oral compounding M. Cavelier, H. Gondé, C. Orsini, A. Coquard, R. Varin, C. Hervouët
CHU de Rouen, France 110 Development and stability of 40 mg/mL amiodarone oral suspension M. Cavelier, H. Gondé, D. Costa, F. Lamoureux, T. Pereira, R. Varin, C. Hervouët
CHU de Rouen, France
E-Posters: Production
Waste of hospital preparations, the example of ceftazidime ophthalmic solution at Angers University Hospital
S. Maisonneuve, V. Lebreton, S. Vrignaud, F. Lagarce
Centre hospitalier universitaire d’Angers, France Hospital preparations : towards the automation of their packaging N. Kervella, A. Bourges, M. Bernard, S. Vrignaud, V. Lebreton
CHU d’Angers, France Emergency opening of sterile preparations unit during COVID-19 pandemic E. Gasperi, F. Bordet, M-L. Maestroni
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France Methotrexate for ectopic pregnancies: a national survey on pharmacy practice I. Challier, M. Le Goff, M. Zeino, S. Chatain, C. Orsini, A. Coquard, R. Varin
CHU de Rouen, France Feedback on 5 months of use of a robotized production system in the Cytotoxic Reconstitution Unit M-L. Ducassou, G. Gaschard, M. Bay
CHU de Poitiers, France Residual volume of anticancer drugs when administering a preparation with filter tubing: What solution? M. Chabert, M. Duval, C. Alessandra
Hôpital Sainte Musse, Toulon, France Manufacturing practices, formulations and reimbursement of topical forms of apamycin in Tuberous Sclerosis of Bourneville: update on French practices A. Moussali, R. Mazet, M Durand, J. Leenhardt, M-D. Desruet, P. Bedouch
Centre Hospitalier Universitaire Grenoble Alpes, France Feedback from temporary relocation of a sterile production activity M. Sangnier, G. Bougueon, A. Berroneau, S. Crauste-Manciet
CHU de Bordeaux, France Production of an injectable bacteriophage preparation: identification of the associated critical points L. Delnoy, D. Lannoy, B. Palas, M. Roche, C. Berneron, M. Titecat, P. Odou
CHU de Lille, France Subcontracting of the reconstitution of anti-cancer drugs: feedback from the principal 2 years after implementation G. Pottier, E. Desaintfuscien, J. Courtin, M. Vasseur, P. Odou, A. Deswarte
CH d’Armentières, CHU de Lille, France
Implementation of dose-banding in our hospital: ready-to-infuse bags or standardized dose batches S. Couture, M. Malassigné, MC. Casaurancq, C. Burtin
Centre Hospitalier de la Côte Basque, Bayonne, France
Impact study of eye drop batch production C. Rode, O. Chopart, A. Khan, B. Dessane, V. Servant, A. Venet, S. Crauste-Manciet
CHU de Bordeaux, France
Centre hospitalier universitaire d’Angers, France Hospital preparations : towards the automation of their packaging N. Kervella, A. Bourges, M. Bernard, S. Vrignaud, V. Lebreton
CHU d’Angers, France Emergency opening of sterile preparations unit during COVID-19 pandemic E. Gasperi, F. Bordet, M-L. Maestroni
Centre Hospitalier Sud Francilien, Corbeil-Essonnes, France Methotrexate for ectopic pregnancies: a national survey on pharmacy practice I. Challier, M. Le Goff, M. Zeino, S. Chatain, C. Orsini, A. Coquard, R. Varin
CHU de Rouen, France Feedback on 5 months of use of a robotized production system in the Cytotoxic Reconstitution Unit M-L. Ducassou, G. Gaschard, M. Bay
CHU de Poitiers, France Residual volume of anticancer drugs when administering a preparation with filter tubing: What solution? M. Chabert, M. Duval, C. Alessandra
Hôpital Sainte Musse, Toulon, France Manufacturing practices, formulations and reimbursement of topical forms of apamycin in Tuberous Sclerosis of Bourneville: update on French practices A. Moussali, R. Mazet, M Durand, J. Leenhardt, M-D. Desruet, P. Bedouch
Centre Hospitalier Universitaire Grenoble Alpes, France Feedback from temporary relocation of a sterile production activity M. Sangnier, G. Bougueon, A. Berroneau, S. Crauste-Manciet
CHU de Bordeaux, France Production of an injectable bacteriophage preparation: identification of the associated critical points L. Delnoy, D. Lannoy, B. Palas, M. Roche, C. Berneron, M. Titecat, P. Odou
CHU de Lille, France Subcontracting of the reconstitution of anti-cancer drugs: feedback from the principal 2 years after implementation G. Pottier, E. Desaintfuscien, J. Courtin, M. Vasseur, P. Odou, A. Deswarte
CH d’Armentières, CHU de Lille, France
Implementation of dose-banding in our hospital: ready-to-infuse bags or standardized dose batches S. Couture, M. Malassigné, MC. Casaurancq, C. Burtin
Centre Hospitalier de la Côte Basque, Bayonne, France
Impact study of eye drop batch production C. Rode, O. Chopart, A. Khan, B. Dessane, V. Servant, A. Venet, S. Crauste-Manciet
CHU de Bordeaux, France
